Inventor · disambiguated record
Etienne Jacotot
Also filed as: JACOTOT ETIENNE · JACOTOT ETIENNE DANIEL FRANCOI · JACOTOT ETIENNE DANIEL FRANCOIS
7 granted patents·13 pending applications·10 citations·filing 2001–2022
77Inventor score
Top patents by PatentIndex Score
20 records- 0171US7642051B2Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)PASTEUR INSTITUT·Filed 2005·Granted Jan 5, 2010·3 cites·12 claims
- 0269US7056735B2Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator)UNIV COMPIEGNE TECH·Filed 2001·Granted Jun 6, 2006·4 cites·25 claims
- 0368US8809346B2ANT-ligands molecules and biological applicationsBORGNE-SANCHEZ ANNIE·Filed 2009·Granted Aug 19, 2014·2 cites·1 claims
- 0467US11407741B2Compounds and their use as selective inhibitors of caspase-2UNIV PARIS·Filed 2018·Granted Aug 9, 2022·1 cites·19 claims
- 0557US2023008495A1Novel compounds and their use as selective inhibitors of caspase-2UNIV PARIS·Filed 2022·Application pending·0 cites
- 0655US2023372292A1Treatments of coronavirus infections, cytokine release syndrome, cytokine storm syndrome, or diseases associated with excessive activation of inflammasomes by the use of inhibitors of inflammatory caspasesINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0754US2004265300A1Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)Filed 2003·Application pending·0 cites
- 0850US2003077826A1Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)Filed 2002·Application pending·0 cites
- 0948US2010184703A1Use of peptide derivatives for treating pathologies resulting from ischemiaCHIESI FARMA SPA·Filed 2008·Application pending·0 cites
- 1047US2008199899A1Method For Screening Modulators of Mitochondrial Functioning and New Modulators ObtainedJACOTOT ETIENNE·Filed 2003·Application pending·0 cites
- 1146US2010113369A1Means for preventing and treating cellular death and their biological applicationsTHERAPTOSIS S A·Filed 2009·Application pending·0 cites
- 1244US2004072146A1Mechanism of mitochondrial membrane permeabilization by HIV-1 Vpr, mimetics of Vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of Vpr with ANTFiled 2003·Application pending·0 cites
- 1343US2002076693A1Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic usesINST PASTEUR AND CT NAT DE LA·Filed 2001·Application pending·0 cites
- 1440US10961219B2Derivatives and their use as selective inhibitors of caspase-2INST NAT SANTE RECH MED·Filed 2017·Granted Mar 30, 2021·0 cites·23 claims
- 1540US9657031B2Ant-ligands molecules and biological applicationsMITOLOGICS·Filed 2014·Granted May 23, 2017·0 cites·16 claims
- 1638US2006241034A1Means for preventing and treating cellular death and their biological applicationsCHAUVIER DAVID·Filed 2004·Application pending·0 cites
- 1736US2012329721A1Means for preventing and treating cellular death and their biological applicationsCHAUVIER DAVID·Filed 2012·Application pending·0 cites
- 1832US8173600B2Caspase-2 inhibitors and their biological applicationsCHAUVIER DAVID·Filed 2005·Granted May 8, 2012·0 cites·7 claims
- 1932US2008171697A1Peptides Having For Example Antiangiogenic Activity and Applications Thereof In TherapeuticsJACOTOT ETIENNE·Filed 2004·Application pending·0 cites
- 2030US2006210535A1Means for regulating the expression of human isoforms of antBORGNE ANNIE·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Etienne Jacotot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →